Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 21.16 Million USD | -36.79% |
| 2022 | 33.49 Million USD | -26.41% |
| 2021 | 45.5 Million USD | 32.84% |
| 2020 | 34.25 Million USD | -13.58% |
| 2019 | 39.64 Million USD | 646.69% |
| 2018 | 5.3 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 5.9 Million USD | -7.28% |
| 2023 Q1 | 6.36 Million USD | -0.2% |
| 2023 Q3 | 5.02 Million USD | -14.78% |
| 2023 Q4 | 4.33 Million USD | -13.8% |
| 2023 FY | 21.16 Million USD | -36.79% |
| 2022 Q4 | 6.37 Million USD | -4.89% |
| 2022 Q3 | 6.7 Million USD | -14.36% |
| 2022 FY | 33.49 Million USD | -26.41% |
| 2022 Q2 | 7.82 Million USD | -21.1% |
| 2022 Q1 | 9.92 Million USD | -12.6% |
| 2021 FY | 45.5 Million USD | 32.84% |
| 2021 Q4 | 11.35 Million USD | -7.09% |
| 2021 Q3 | 12.21 Million USD | 2.36% |
| 2021 Q2 | 11.93 Million USD | 19.38% |
| 2021 Q1 | 9.99 Million USD | 4.26% |
| 2020 Q4 | 9.59 Million USD | 41.36% |
| 2020 Q3 | 6.78 Million USD | -17.59% |
| 2020 Q2 | 8.23 Million USD | -14.72% |
| 2020 Q1 | 9.65 Million USD | -49.44% |
| 2020 FY | 34.25 Million USD | -13.58% |
| 2019 Q1 | 6.37 Million USD | 0.0% |
| 2019 FY | 39.64 Million USD | 646.69% |
| 2019 Q3 | 12.68 Million USD | 53.75% |
| 2019 Q4 | 19.09 Million USD | 50.58% |
| 2019 Q2 | 8.24 Million USD | 29.32% |
| 2018 FY | 5.3 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -156.505% |
| Alpha Teknova, Inc. | 45.85 Million USD | 53.839% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | 89.199% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | 52.805% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | 86.704% |
| Cosmos Health Inc. | 26.18 Million USD | 19.143% |
| Journey Medical Corporation | 54.59 Million USD | 61.225% |
| Embecta Corp. | 528.4 Million USD | 95.994% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | 92.214% |
| Dynavax Technologies Corporation | 219.14 Million USD | 90.34% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 96.412% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 93.514% |
| PainReform Ltd. | 9.58 Million USD | -120.879% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -61.294% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -61.294% |
| SCYNEXIS, Inc. | 51.84 Million USD | 59.171% |
| Safety Shot Inc | 12.1 Million USD | -74.81% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -589.726% |
| Procaps Group, S.A. | 199.47 Million USD | 89.388% |
| Theratechnologies Inc. | 72.75 Million USD | 70.904% |
| Harrow Health, Inc. | 89.97 Million USD | 76.472% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -124.105% |
| Biofrontera Inc. | 39.95 Million USD | 47.023% |
| DURECT Corporation | 43.71 Million USD | 51.575% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 95.998% |
| Cronos Group Inc. | 96.7 Million USD | 78.111% |
| OptiNose, Inc. | 85.1 Million USD | 75.125% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | 90.88% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | 45.933% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 321.41% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 93.261% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -117.546% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | 50.816% |
| Radius Health, Inc. | 265.92 Million USD | 92.04% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -52.934% |
| ProPhase Labs, Inc. | 37.85 Million USD | 44.074% |
| Phibro Animal Health Corporation | 260.29 Million USD | 91.867% |
| Procaps Group S.A. | 187.24 Million USD | 88.694% |
| Alvotech | 285.43 Million USD | 92.584% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -115.461% |
| Viatris Inc. | 5.96 Billion USD | 99.645% |
| Rockwell Medical, Inc. | 15.37 Million USD | -37.694% |
| Aytu BioPharma, Inc. | 59.84 Million USD | 64.624% |
| SIGA Technologies, Inc. | 22.04 Million USD | 3.965% |
| Tilray Brands, Inc. | 251.35 Million USD | 91.578% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | 56.831% |
| Shineco, Inc. | 17.94 Million USD | -17.946% |
| PetIQ, Inc. | 192.72 Million USD | 89.016% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -430.4% |
| Incannex Healthcare Limited | 30.05 Million USD | 29.561% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 98.674% |
| Alimera Sciences, Inc. | 62.64 Million USD | 66.206% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -2676.291% |
| Assertio Holdings, Inc. | 368.58 Million USD | 94.257% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -259.676% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -18.87% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -0.603% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | 87.168% |
| Hempacco Co., Inc. | 7.59 Million USD | -178.67% |
| Talphera, Inc. | 11.99 Million USD | -76.497% |
| Alvotech | 285.43 Million USD | 92.584% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 84.956% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 93.862% |
| Currenc Group, Inc. | 24 Million USD | 11.804% |
| Kamada Ltd. | 45.42 Million USD | 53.399% |
| Indivior PLC | 911 Million USD | 97.676% |
| Evoke Pharma, Inc. | 12.4 Million USD | -70.585% |
| Flora Growth Corp. | 10.57 Million USD | -100.104% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -0.603% |
| Evolus, Inc. | 189.75 Million USD | 88.844% |
| HUTCHMED (China) Limited | 436.23 Million USD | 95.147% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | 86.266% |
| Akanda Corp. | 3.48 Million USD | -507.692% |